The director of the Kansas City Multiple Sclerosis Center at College Park Neurology, discusses goals of therapy in patients with relapsing multiple sclerosis, especially for the subset of patients in which steroids are not an option or are ineffective
Jeffrey Kaplan, MD — May 2020
::::::::::::::::::::::::::::::::::::::;;;;;;;;;;;;;;;;;;;;;::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Information Shared by: MSViewsandNews,
to and for those affected by Multiple Sclerosis
::::::::::::::::::::::::::::::::::::::;;;;;;;;;;;;;;;;;;;;;:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews